Navigation Links
PM Versus MIM: TM&S President to Explain Niche Metal Fabrication Methods During IHS GlobalSpec Event

Minneapolis, Minnesota (PRWEB) September 24, 2013

Derek Rasmussen, President of TM&S, LLC, will present “Powder Metal Part Design Fundamentals,” a free Webinar taking place on October 23, 2013, at 12:30 P.M. EST, during IHS GlobalSpec’s Aerospace Technology online event.

The informational session will help engineering, sales, and other professionals involved in component design for manufacture (DFM) understand the characteristics and best uses for Press and Sinter (conventional powder metal, or PM) and Metal Injection Molding (MIM), respectively. Both are classified as powder metal technologies and are used in the medical device, computer, communications, automotive, firearms, defense, aerospace, and consumer electronics industries. But there are vast differences between them in terms of manufacturing processes and capabilities.

With 20 years’ experience in component design, mold design, part processing, and troubleshooting high-volume manufacturing processes to increase yields, Mr. Rasmussen is uniquely qualified to give attendees a fundamental comparison of PM and MIM manufacturing technologies. His Webinar will help participants improve their cost analysis and sourcing decisions, as well as enhance communication with suppliers.

TM&S, LLC, is a trusted resource for custom component designers and manufacturers. It exclusively represents four companies specializing in niche powder metal technologies: ecoMIM of Retsag, Hungary (Metal Injection Molding); element22 of Kiel, Germany (Titanium MIM); FMS Corporation of Minneapolis, Minnesota (Press and Sinter and Micro MIM); and Liquidmetal Technologies of Rancho Santa Margarita, California. Their complementary capabilities allow TM&S to provide the best solution for any component suited to powder metal technology, whether round parts, complex geometric profiles, micro parts with high tolerances, or low-cost Titanium parts.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Lillys Investigational GLP-1 Receptor Agonist, Dulaglutide, Showed Superior Glycemic Control Versus Comparators in Patients with Type 2 Diabetes
2. TM&S Opens Office Dedicated to Powder Metal, Metal Injection Molding and Liquid Metal
3. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
4. Elsevier / MEDai Appoints Tom Zajac as New President
5. GenVec President and Chief Executive Officer Announces Retirement
6. Michael A. Marletta Takes Office as New President of Scripps Research Institute
7. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 30th Annual J.P. Morgan Healthcare Conference in San Francisco, CA
8. Selexis SA Appoints Yemi Onakunle as Vice President of Strategic and Market Development
9. Neuralstem President and CEO to Update Ongoing ALS and NSI-189/Major Depressive Disorder Trials at 2012 Biotech Showcase
10. Zyga Technology, Inc. Announces the Appointment of Jim Bullock as President and CEO
11. Cepheid Welcomes Senior Vice President of Human Resources
Post Your Comments:
(Date:10/11/2017)... N.C. (PRWEB) , ... October 11, 2017 , ... ... ARCS® Foundation President Andi Purple announced Dr. Suneel I. Sheikh, the co-founder, ... ( ASTER Labs ), Inc. has been selected for membership in ARCS ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for ... June 2018 in San Francisco, CA. The Summit brings together current and former FDA ... board directors and government officials from around the world to address key issues in ...
(Date:10/11/2017)... ROTTERDAM, the Netherlands and LAGUNA HILLS, ... that The Institute of Cancer Research, London ... will use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify ... high-risk trial known as MUK nine . The University ... this trial, which is partly funded by Myeloma UK, and ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
Breaking Biology Technology:
(Date:4/13/2017)... , April 13, 2017 UBM,s Advanced ... will feature emerging and evolving technology through ... Innovation Summits will run alongside the expo portion of ... sessions, panels and demonstrations focused on trending topics within ... advanced design and manufacturing event will take place June ...
(Date:4/11/2017)... Research and Markets has announced the addition of the ... ... to grow at a CAGR of 30.37% during the period 2017-2021. ... been prepared based on an in-depth market analysis with inputs from ... prospects over the coming years. The report also includes a discussion ...
(Date:4/6/2017)... 6, 2017 Forecasts by Product ... Readers, by End-Use (Transportation & Logistics, Government & Public ... & Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business ... Are you looking for a definitive report on ... ...
Breaking Biology News(10 mins):